Peering Into Vertex Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Vertex Pharmaceuticals's (NYSE:VRTX) short percent of float has fallen 10.92% since its last report, with 2.73 million shares sold short, which is 1.06% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards the stock. Compared to its peers, Vertex has less short interest, with an average of 4.20% for its peer group.
July 03, 2023 | 3:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Decrease in short interest could indicate a more bullish sentiment towards Vertex Pharmaceuticals.
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. A decrease in short interest can signal that investors have become more bullish, which could potentially lead to an increase in the stock's price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100